<DOC>
	<DOCNO>NCT00031798</DOCNO>
	<brief_summary>RATIONALE : Methylphenidate may decrease side effect radiation therapy . It yet know methylphenidate effective improving quality life patient primary metastatic brain tumor . PURPOSE : Randomized phase III trial determine effectiveness methylphenidate improve quality life patient brain tumor undergoing radiation therapy .</brief_summary>
	<brief_title>Methylphenidate Improve Quality Life Patients Undergoing Radiation Therapy Brain Tumors</brief_title>
	<detailed_description>OBJECTIVES : - Determine effect d-methylphenidate fatigue patient receive radiotherapy primary metastatic brain tumor . - Determine effect drug quality life patient . - Determine effect drug depression patient . - Determine effect drug global neurocognitive function , include attention concentration , memory , language , visuospatial skill , executive function , patient . OUTLINE : This randomize , placebo-controlled , double-blind , multicenter study . Patients stratify tumor type ( primary v metastatic ) , treatment ( radiotherapy v radiotherapy chemotherapy ) , Karnofsky performance status ( 70 % 80 % vs 90 % 100 % ) . Patients randomize one two treatment arm . All patient undergo radiotherapy week 1-4 . - Arm I : Patients receive oral d-methylphenidate twice daily week 1-12 . - Arm II : Patients receive oral placebo twice daily week 1-12 . In arm , quality life assess baseline , end radiotherapy , 4 , 8 , 12 week radiotherapy . Patients follow 4 week . PROJECTED ACCRUAL : A total 200 patient ( 100 per treatment arm ) accrue study within 18 month .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm metastatic brain tumor OR Histologically confirm primary brain tumor Glioblastoma multiforme Anaplastic astrocytoma Anaplastic oligodendroglioma Anaplastic mixed oligoastrocytoma Lowgrade glioma Meningioma Ependymoma Planned external beam cranial radiotherapy ( partial whole brain ) total dose least 25 Gy least 10 fraction 180300 cGy PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 70100 % Life expectancy : At least 3 month Hematopoietic : WBC ≥ 1,500/mm^3 Hemoglobin ≥ 10.0 g/dL Platelet count ≥ 75,000/mm^3 Hepatic : Not specify Renal : Not specify Cardiovascular : No hypertension cardiovascular disease require antihypertensive and/or cardiovascular medication Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No serious medical psychiatric illness would preclude study participation No hypersensitivity study drug No history steroid psychosis No family history active Tourette 's Syndrome No prior active glaucoma PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Prior concurrent chemotherapy allow Endocrine therapy : Concurrent steroid allow Radiotherapy : See Disease Characteristics Prior radiotherapy allow except brain ( include stereotactic radiosurgery ) No concurrent craniospinal axis radiotherapy Surgery : Not specify Other : No prior concurrent medication attention deficit disorder , anxiety disorder , schizophrenia , substance abuse No concurrent antidepressant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>fatigue</keyword>
	<keyword>depression</keyword>
	<keyword>quality life</keyword>
	<keyword>cognitive/functional effect</keyword>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult brain stem glioma</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult tumor metastatic brain</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>adult meningioma</keyword>
	<keyword>adult anaplastic ependymoma</keyword>
	<keyword>adult myxopapillary ependymoma</keyword>
	<keyword>adult ependymoblastoma</keyword>
	<keyword>adult pilocytic astrocytoma</keyword>
	<keyword>adult subependymoma</keyword>
	<keyword>adult grade III meningioma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
	<keyword>adult grade II meningioma</keyword>
</DOC>